Clinical trial
Impact of Finerenone in Combination With Sodium Glucose Cotransporter-2 Inhibitor in Patients With Heart Failure
NCT07351864 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Finerenone in Combination With Sodium Glucose Cotransporter-2 Inhibitor in Patients With Heart Failure
- Lead sponsor
- Mansoura University
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- January 18, 2026
- Completion date
- October 31, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.